The End-Tidal CO2 Module market is dominated by North America, which holds a 38% value share, driven by advanced healthcare infrastructure, high adoption of non-invasive monitoring technologies, and robust R&D investments. Europe follows with a 29% share, bolstered by stringent patient safety regulations, aging demographics, and ecosystem maturity in critical care. The Asia Pacific region, growing at the fastest CAGR, is projected to capture 22% by 2030, fueled by rising ICU capacity, government healthcare digitization initiatives, and increasing demand for cost-effective monitoring solutions. Latin America and the Middle East & Africa trail with 7% and 4% shares, respectively, but show potential through expanding private healthcare infrastructure and policy reforms.